95 related articles for article (PubMed ID: 3099031)
1. [Thymidylate synthase inhibition in malignant tumors after oral administration of UFT].
Yamamura M; Seiro T; Yamamoto M; Shirasaka T; Miyauchi S; Fujii S
Gan No Rinsho; 1986 Nov; 32(14):1838-40. PubMed ID: 3099031
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor].
Fujita M; Fujita F; Uchida J; Takeda S; Yamada Y; Taguchi T
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):627-32. PubMed ID: 2108611
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA
Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.
Spears CP; Gustavsson BG; Mitchell MS; Spicer D; Berne M; Bernstein L; Danenberg PV
Cancer Res; 1984 Sep; 44(9):4144-50. PubMed ID: 6744325
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer.
Ichikura T; Tomimatsu S; Okusa Y; Yahara T; Uefuji K; Tamakuma S
Cancer Chemother Pharmacol; 1996; 38(5):401-5. PubMed ID: 8765432
[TBL] [Abstract][Full Text] [Related]
7. [UFT/CDDP preoperative chemotherapy for progressive gastric cancer--histological antitumor effects and thymidylate synthase inhibition rate].
Tanaka S; Umeno T; Mitsuishi K; Tomita A; Ootsuka K; Mori H; Nakamura H; Ikeda S
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1947-51. PubMed ID: 7487125
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
9. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
[TBL] [Abstract][Full Text] [Related]
10. [Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat].
Mitsuishi K; Umeno T; Tanaka S; Kimura H; Fuchino Y; Tomita A; Ikeda S
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1119-24. PubMed ID: 9239165
[TBL] [Abstract][Full Text] [Related]
11. [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Uyama R; Yoshizawa Y; Tajiri T; Endo Y; Mitsuya T; Sanada Y
Gan To Kagaku Ryoho; 2006 May; 33(5):625-9. PubMed ID: 16685161
[TBL] [Abstract][Full Text] [Related]
12. [Innate resistance to thymidylate synthase inhibition after 5-fluorouracil treatment--a rationale of combined use of cisplatin and its optimal administration dose].
Omura K; Hashimoto T; Kawakami K; Kanehira E; Watanabe T; Hirano K; Watanabe S; Watanabe Y; Shirasaka T
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2007-11. PubMed ID: 8085851
[TBL] [Abstract][Full Text] [Related]
13. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
[TBL] [Abstract][Full Text] [Related]
14. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
Kanimoto Y; Suzuki Y; Miwa Y; Akino H; Isomatu Y; Okada K
Hinyokika Kiyo; 1991 Mar; 37(3):229-33. PubMed ID: 1648873
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue.
Kawakami K; Omura K; Kanehira E; Watanabe G
Anticancer Res; 2001; 21(1A):285-9. PubMed ID: 11299748
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
[TBL] [Abstract][Full Text] [Related]
17. The number of 5-fluoro-2'-deoxyuridine-5'-monophosphate binding sites and reduced folate pool in human colorectal carcinoma tissues: changes after tegafur and uracil treatment.
Omura K; Kawakami K; Kanehira E; Nagasato A; Kawashima S; Tawaraya K; Watanabe S; Hirano K; Shirasaka T; Watanabe Y
Cancer Res; 1995 Sep; 55(17):3897-901. PubMed ID: 7641209
[TBL] [Abstract][Full Text] [Related]
18. [UFT-E granule compliance in postoperative adjuvant chemotherapy].
Komoriyama H; Hanai A; Kanasugi K; Hagiwara M; Yamaguchi S
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1321-7. PubMed ID: 10478186
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma.
Kawano K; Goto H; Kanda T; Yanagisawa S
Int J Oral Maxillofac Surg; 2003 Dec; 32(6):633-7. PubMed ID: 14636615
[TBL] [Abstract][Full Text] [Related]
20. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
